Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation with Coronary or Peripheral Artery Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation with Coronary or Peripheral Artery Disease

Published:2020-03-28 Issue:2 Volume:61 Page:231-238
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Zhang Hao¹,Xue Zhengbiao²,Yi Dongqian³,Li Xiaobo¹,Tan Yanwu¹,Li Jianwen¹

Affiliation:

1. Department of Cardiovascular Medicine, Xiangdong Hospital Hunan normal University

2. Department of Critical Care Medicine, First Affiliated Hospital of Gannan Medical University

3. Department of Gastroenterology, Xiangdong Hospital Hunan normal University

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/61/2/61_19-202/_pdf

Reference44 articles.

1. 1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke 1991; 22: 983-8.

2. 2. Lip GYH. The abc pathway: An integrated approach to improve af management. Nat Rev Cardiol 2017; 14: 627-8.

3. 3. Lip G, Freedman B, De Caterina R, Potpara TS. Stroke prevention in atrial fibrillation: Past, present and future. Comparing the guidelines and practical decision-making. Thromb Haemost 2017; 117: 1230-9.

4. 4. Cheng CM, Lin CH, Chou P, Jong GP. Antithrombotic treatment may reduce mortality among new-onset atrial fibrillation patients with gray-zone risk of stroke. Int Heart J 2019; 60: 303-9.

5. 5. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Cardiol 2019; 74: 104-32.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02

2. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation;Journal of the American College of Cardiology;2024-01

3. Real-world clinical outcomes of oral anticoagulants among Japanese patients with atrial fibrillation and concomitant coronary artery disease;IJC Heart & Vasculature;2023-12

4. Effects of oral anticoagulant therapy in patients with pulmonary diseases;Frontiers in Cardiovascular Medicine;2022-08-10

5. Antithrombotic Treatment for Peripheral Arterial Occlusive Disease;Deutsches Ärzteblatt international;2021-08-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3